Abstract:Background Interferon-γ (IFN-γ) is regarded as a potent antitumor agent, but its clinical application is limited by its short half-life and significant side effects. In this paper, we tried to develop IFN-γ gene therapy by a replication defective adenovirus encoding the human IFN-γ (Ad-IFNγ), and evaluate the antitumoral effects of Ad-IFNγ on nasopharyngeal carcinoma (NPC) cell lines in vitro and in xenografts model. Methods The mRNA levels of human IFN-γ in Ad-IFNγ-infected NPC cells were detected by reverse transcription-polymerase chain reaction (RT-PCR), and IFN-γ protein concentrations were measured by enzyme-linked immunosorbent assay (ELISA) in the culture supernatants of NPC cells and tumor tissues and bloods of nude mice treated with Ad-IFNγ. The effects of Ad-IFNγ on NPC cell proliferation was determined using MTT assay, cell cycle distribution was determined by flow cytometry analysis for DNA content, and cells apoptosis were analyzed by Annexin V-FITC/7-AAD binding assay and hoechst 33342/PI double staining. The anti-tumor effects and toxicity of Ad-IFNγ were evaluated in BALB/c nude mice carrying NPC xenografts. Results The results demonstrated that Ad-IFNγ efficiently expressed human IFN-γ protein in NPC cell lines in vitro and in vivo . Ad-IFNγ infection resulted in antiproliferative effects on NPC cells by inducing G1 phase arrest and cell apoptosis. Intratumoral administration of Ad-IFNγ significantly inhibited the growth of CNE-2 and C666-1 cell xenografts in nude mice, while no significant toxicity was observed. Conclusions These findings indicate IFN-γ gene therapy mediated by replication defective adenoviral vector is likely a promising approach in the treatment of nasopharyngeal carcinoma.

Genetically engineered Newcastle disease virus expressing human interferon-λ1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response

Adenovirus-Mediated Interferon-Gamma Transfer Inhibits Growth Of Transplanted Htlv-I Tax Tumors In Mice

Effects of gamma-interferon gene-modified hepatocytes on murine implanted liver carcinoma

Adenovirus-mediated Delivery of Interferon-Γ Gene Inhibits the Growth of Nasopharyngeal Carcinoma

Dynamic Distribution and Expression in Vivo of the Human Interferon Gamma Gene Delivered by Adenoviral Vector.

Antitumor Effects Of Interleukin-18 Gene-Modified Hepatocyte Cell Line On Implanted Liver Carcinoma

Genetically Engineered Newcastle Disease Virus Expressing Interleukin-2 and TNF-related Apoptosis-Inducing Ligand for Cancer Therapy.

Inhibition of Tumor Growth by Recombinant Adenovirus Containing Human Lactoferrin Through Inducing Tumor Cell Apoptosis in Mice Bearing Emt6 Breast Cancer

The effect of IFNγ gene modified dendritic cells on T cell proliferation and eradication of tumor cells

Lentivirus-mediated Gene Transfer of Human Strail Induced Apoptosis in SGC-7901 Cells

Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.

Anti-Tumor Immune Response Mediated by Newcastle Disease Virus Hn Gene

Significant Antitumor Activity Of Oncolytic Adenovirus Expressing Human Interferon-Beta For Hepatocellular Carcinoma

[Construction of Recombinant Adenovirus Carrying Human IFNgamma Gene by in Vitro Ligation and Its Expression].

Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy

Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1

Adenovirus‐mediated Interferon‐γ Gene Therapy Induced Human Pancreatic Carcinoma Capan‐2 Cell Apoptosis in Vitro and in Vivo

Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy

Anti-tumor efficacy and pre-clinical immunogenicity of IFNα2a-NGR.

780. Efficient Adenovirus-Mediated Human Interferon-gamma Transfer into C6 Glioma Cells

Antitumor Effects of Newcastle Disease Virus Hemagglutinin-Neuraminidase Used As a Molecular Adjuvant